Entries by Jill Ettinger

Psychedelic Business News Spotlight: December 3, 2020

This week in psychedelic business news: Numimus Wellness Inc. annouces a major partnership, Field Trip expands its investor relations, serial entrepreneur Peter Thiel invests in psychedelics for mental health treatment, and more. Numimus Wellness Inc., which is developing psychedelic-assisted psychotherapies, announced a partnership with MAPS, the Multidisciplinary Association for Psychedelic Studies. The first-of-its-kind partnership will involve clinical trials in […]

Mike Tyson Credits 5-MeO for His Return to Boxing

The outspoken former undisputed heavyweight boxing champion Mike Tyson, now 54, says an experience with the potent psychedelic 5-MeO-DMT sparked his return to the ring this past holiday weekend. The exhibition fight against Roy Jones Jr. was declared a draw. But for Tyson, it was all victory. It was his first fight in 15 years. “I […]

Peter Thiel Invests $12 Million In Psychedelic Drug Manufacturer

Billionaire tech investor Peter Thiel is the latest to join the booming psychedelic industry. The PayPal co-founder backed Berlin’s ATAI Life Sciences in a $125 million series C funding round. Thiel’s investment firm, Thiel Capital, invested $12 million. Thiel joins Apeiron Investment Group, Catalio Capital Management, Future Ventures, Galaxy Investment Partners, Falcon Edge Capital, and […]

World’s First Psychedelic Psychotherapy Clinic to Open in January

The world’s first psychedelic-assisted therapy clinic of its kind is set to open its doors in the UK. AWAKN uses Ketamine, MDMA, and psilocybin alongside psychotherapy to treat mental health disorders. Run by Dr. Ben Sessa, AWAKN was formerly Mandala Therapy Limited, run by the author, researcher, and psychiatrist. Acquired earlier this year, Sessa now […]

Ready to Become a Mushroom Master?

Mushrooms are having a moment. From sustainable replacements for meat and leather to holding great potential in rewriting mental health treatments, there’s a ‘shroom boom fully underway. And leading the mycophilia revolution this week is the Mushroom Conference: A Molecular Masterclass. It takes to the Internet with a series of expert-led panels over two days, […]

Psilocybin Four Times More Effective Than Antidepressants, Study Finds

New research into the benefits of psilocybin point to significant improvements for those suffering with depression. The new study, published in the journal JAMA Psychiatry found the impact of psilocybin was “more than four times greater” than typical antidepressants. Twenty-seven people participated in the research conducted by Johns Hopkins University and Ohio State University. “The effect happened within one […]

Oregon Becomes the First U.S. State to Legalize Psilocybin

In an expected win for the nascent psychedelics industry, Oregon voters passed Measure 29 last night, legalizing the supervised use of psilocybin for medicinal purposes. The Measure passed by a 56.1 percent vote, bringing victory to the well-funded initiative helmed by husband-and-wife team Sheri and Thomas Eckert. The Eckerts are both psychotherapists and advocates for […]

Washington D.C. Votes In Favor of Psychedelics

Residents in Washington D.C. have voted to decriminalize psychedelic substances including psilocybin. The measure, Initiative 81, is also known as the Entheogenic Plant and Fungus Policy Act of 2020. As polls closed Tuesday evening, early results showed the initiative passing with about 75 percent of voters in favor of the measure. D.C. now joins several cities […]